Stephen Colvill is Executive Director of RISCS, a nonprofit rating and certification organization for drug supply chains, and a researcher at the Duke-Margolis Center for Health Policy, where he is leading the launch of the new Duke-Margolis Drug Supply Chain Resilience and Advanced Manufacturing Consortium. Prior to co-founding RISCS, Stephen held various roles at Pfizer and Hospira in supply chain, manufacturing, finance, marketing, commercial portfolio management, and business analytics. He serves as a board member for the End Drug Shortages Alliance and Angels for Change, and recent national speaking engagements included the HSCA National Pharmacy Forum, ASHP Midyear Meeting, and NASEM event on Innovations in Pharmaceutical Manufacturing on the Horizon."